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a 16-segment construct for both ECHO and g-SPECT. The motion m each 
segment was graded from 1 (norn~i) Io 4 (dyskinelic), 
Tim correlations belween g-SPECT- and ECHO regarding the end-systo!~c 
volume (ESV), end,diastel~c volume (EDV) and LV eteclion fraction (EF) wore 
good: 0,821, 0.787, and 0,768, respe¢lively (for all correlations, p ~ 00001 ). 
Absolute values wore simdar withg-SPECT and ECHO with respect to ESV 
(76 ~ 6G ml va 70 ¢ 42 ml, p = 0.52), EDV (t27 ± 67 mt vs 131 ~ ~J~ m!. p 
=, 024) and LV.EF (46 ~ 16% v~ 51 ± 17%, p = 0,08). Agmen~nt between 
g-SPECT and ECHO with reslx~:l to onm~al vs abnormal watt motion was 
82%,, exact ~ t  fo~ wall regimen ~ wa~ 7L~, 
Tht~, g.SPECT Is an a¢c~ra~ techmque for the evaluahon o! globs! and 
ml;~oal LV fun¢lmn and vot~q~_~, when o0mp~r~l to ECHO, 
I'1 ie~i461 ~!  I.~lt v~ulc.lar F.ncUon A. .=menz  
UMng ~ SPECT-~I :  Comparison Wilh 
Ech~:ardiognq~y 
T.M Baleman, A. ~k i ,  C Bamharl. JH  O*Keele, P Jones 
~n~eca ekeare ~te ,  ~ C~ ~ USA 
Backgn~qm~ Quanl~alNe measures of left ~entncular (LV) functlofl such 
electra f r~mn (EF) an~ ~ iv) at end dmslole tED) and end systole 
(ES) am het~ m ma..,ta~ng pa~ wtlh known oe suspe~ed CAD "R',ese 
pa~rs  Me routinely measurab~ horn gated SPECT T1-201 myocardial 
perlu~o~ ~ ,  but bare not been va~dated against 2D edno, commonly 
used to~ ~,s 
Methods.- We compared LVEF, EDV and ESV from res~ng gated SPECT 
TI-20t ~th LVEF, ED and ES dlmen~ons iD) by echo in 52 I~tlen~ (both 
tests ~30 d~/s). SPECT meastm~ were from 10-15" ~ u~ng a 
mu~t~teaded electo~, we~g~t-a~usted q3-4.5 mCq Tt-20~ ~ .  LEAP 
coamtato~. 8 tramestcycle, no beat ~ and a commercmJty available 
software program (QGS ° ). Echocardmgmms were acquired using a 2.5/20 
mHz HP transducer, LVEF was by I ~  Sm~pson's Rule. "them were 35 
males; 20 parle.is bad pf,,o~ MI; not're ha~ atrial flb~tstmn. 
Resu,~: SPECT LVEF was 55 +~ 17 (range 24-87), ar¢l echo LVEF was 
53 ± 12 (range 23-75) IP = NS)~ Mean ddferenoe (SPECT-Echo) was 2.6 
95% CI 0.2. 5-4 (p :: 007). Regressmn anah:s~s using toganlhm,c 
scare .showed R = 0 7 fo~ both EDV (D) and ESV (D) 
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Conclusion: Gated SPECT TI-201 and 2D echo quantitative measure- 
ments of LVEF, ED and ES are h~ghly comparable over a b~oad range from 
highly abnormal to normal. 
I 1180-147J Correlation of  Angiographlc Coronary Anatomy With Tc99m Sestamibi SPECT Imaging Using a 
Bal loon Occlus ion Model in Patients Undergoing 
Coronary Angiop lasty  
D.B. Fram, RR. Azar, G. Cyr. C.C. McGill, J.F. Mitchet, F.J. Kieman. 
D. Waters, G.V. Hellor. Hartford Hospital Hartford CT. USA 
SPECT pedusion imaging uses a standard bulls-eye plot with assignment 
of vascula: temtory to predict the "culprit" coronary artery in the evaluation 
of myocardial ischemia. Because of the interpatient variability in coronary 
anatomy this inflexible model may not be accurate. To P.valuate this model. 18 
patmnls undergoing balloon comnar, ang~o~asty wc.e ~ w~ 10--t5 
mCI Tc-99m sestamlt~ a.rm9 the final balloon inflatt,-,.n thus inducl~ ~r~ 
vessel ischomta SPECT imaging was begun wi~m 90 n~nutes of mleClJOn 
Nuclear ,magmg was ,nte~retsd by 3 readers, wt ,K~t knc~,~<~e Of 
mtowontlonal vessel, using a Start(lard l?-segfn~ model, Two zy~ 
were ; ~,~,t to aR~ e~ments to each of the 3 ~ ~ftefiss: 11 the 
~ts~lard model and 21 an angtographlcally.~rected ltu~n!11ent ~#~eby 
each ~nt  was as~,gne¢l Io a coronary mlery based on the ~stnbt~on of 
Ins anent in each patmnt 
Resu/f~: SPECT imaging mv~l~l ¢letects in all ipat ~,'~, Ntcloar m!ef~e. 
t s t~ using the s tan~l  model corre~ly e~enl~ed eagle ~se l  ~ m 
only 3/1§ (17%) patients (pmdcted 2 ~ i~h(~la In 8 patmnts, 3 ~sset 
i sc~ ? paints)  .~ing me ar~0gq~@r~:ted  amgnment, SP~CT 
~mal~ng co.eclly KlenlJled ~ingle vessel i~l~em~ in t6/18 (B~%) pal~m~s, 
Using this mo~L only 2 pts had nuclear de, eels m segments ~ ~ 
subtend ~ inten~entmn vessel. 
Conctu~,z In a b~loon oclua~,n ischen~ model. SPECT ~ma~ng ~,  
curately ,~mt~ies ischen~¢ m~cardisl regmns; however, ftsnda~ r~ctear 
assignment frequently everest;males the number of vascular tsmtenes at- 
fected This may have tmpllCatlons ~ iriterpretstlon of slr~a imaging, 
[ 1180-148 J Incremental Prognostic Value Of ~ SPE~"r 
Frecaon k~ P=~lenta Un~lo ln00t~ 
taotope Exemkle or Adenosine l itms SPECff 
R. Ha~hamovTtch, D. Bemlan, H Lewm, I Cohen, J. Fnedman. 
G. Gen'nano Come# MeScal ~ NY NY CeOa~i-Smal ~ 1  
Center, L4. CA, USA 
Backgammon- The evaluatmn of new technology in a cost-contsmmg env~ro~ 
meat demands val~atmn of teG-.-,.:,k~gy mthe contezt of emsl.~ meda~,es. 
With this in mind. we sought to evaluate the mcreme~al prognostic val~e of 
post-sITess gated SPECT electron fractmn (gSPECT EF) over the informatmn 
y~elde¢ by perfus~n SPECT alone 
Memods: We followed-up 1032 consecutive patents Ipts) who 
stress sastamdx/rast hallium SPECT with post-slress galed SPECT (62% 
exercise slmss, mean age = 67 ± 11; 65% male; mean follow-up 1.7 * 03 
ym) who were found to ha~e 32 bar0 events (HE; MI or cardmc death; 3.6% 
HE rate). Scans were mle~preled using v.~sual assessment of 20 myocard~l  
(seg) and a 5-point scale (0 = nl, 4 = absent linger uptake). The 
summed stress score (ass) was defined as the sum of the 20 segmer~l 
scores. Pts who underwem revasculanzalmn early alter SPECT (<60 days) 
were excluded (n = 13Q) lea~ing a study populalmn ol 902 pls. Multwariable 
Cox propomonal hazards analys=s (CPH) was used to predict the added 
progno~c value of gSPECT EF over SPECT pedusmn data. 
Resu/~ CPH revealed a signlfk~.artt tncrease m ~: w~;h the addition of 
EF to SSS adlustmg for type el stress performed (global ~-~ 34 to 43, p 
0 0001l Pts wl~ abnl scans (SSS >3) were strahfied by thc EF result (EF 
• 50% = 2 0"~vr. EF - 50% = 5 ~/ear :  p .  005. 
Conctus~n: Gated SPECT yzelds tncmmentsl prognast]c value and fur- 
tt'~rs nsk stre'~hcation ofpts w~th abnormal SPECT. 
I 1180-166 i Clinical Course of  Reveme RediMdbul ion on 
Thallium-210 Myocardlel SPECT in Patient= Wilh 
Myocardial  In far~ion 
Kazuya Takehana. Te'~suro Sugmra, Yoshlleru Abe. Kengo Hatsda. 
Sacl '~ Okugawa. Seishi Nakamura. Toshfji hNasaka. Kansei Medical 
Urm~ers~ty. MonguChL Japan 
Background: Reverse reo~stnbuhon (RRD) on thallium-201 myocardial sontlg- 
raphy is thought to be a manttestahon of reperfusion therapy Wall 
abnormal i ty  is obseR,'ed in file RRD segments, but the mechanism 8s~i -  
ated with wall motion abnormality in tt~ RRD segments is yet to be defined. 
We assessed the clinical 5tgnfllcance Of RRD on rest thallium-201 myocar~al 
sontcjraphy in ~ acute phase of myocardial infarction (MI). 
Methods: Thallium-201 and m~fine-t23-BMlPP myocardial SPECT were 
anatyzed  in 26 patients w~th on@vessel disease and successful percutaneous 
transluminal coronary ang~oplasty 7 to 13 ~ays after the onset of MI (acute 
phase) and one month after (follow-up phase) Tomograph*c image of the 
left ventncle were dMded into 11 segments. The segments with RRD on 
thallium-201 SPECT in the acute phase were assessed by iedine-123-BMIPP 
uptake and two-dimensional echocardiography 
Results: Seventy-two segments howed FIRD on tballium-201 SPECT; 69 
segments (96%) had suppressed BMIPP uptake m the acute phase. Norm of 
the patients had restenosis in the artery supplying the myocardial segment 
exhibiting RRD at one month after the onset. In the follow-up phase, 37 
of 72 RRD segments become normal, and BMIPP uptake normalized in all 
37 segmets. In the acute phase. 70 of 72 segments with RRD exhibffeo 
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Conclusions: The majority of RRD segments on thallium.201 had sup. 
pressed fatty-acid metabolism with wall motion abnormality in the acute 
phase, b.t wag motion abnormality of the RRO segments improved with 
recovery of fatty.acid metabolism in the follow.up phase, 
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~ Flbrlnolytlc by Estrogen Therapy Potentiation it 
Conventional gouge In Poetmenopauul Woman 
la Independent of  Co |gu l |Uon  Pathway Activation 
K,K, Koh, M,K, Home, lit, R,O, Cannon, IlL NHLe/~nd Gila/col P~thology 
D~ffrnr~f, NIH, eel/made, MO, USA 
Estrogen usa in ge~,erql h~a boon ~0soolaiod with in~ ,~aaed risk of venoos 
thmmboomboll and hU b~n shown to S~tlvete do,~a,dapandentty coag, 
ulation I~thw~ya, We h~vo recently shown that oral 0strogen therapy af 
conventional dosage potentiltet fibrinotysls In postmanopausal woman, n 
pfootaa 1hat could !~ A ¢one@quonco f prim~n/aatrogen.lnduced oeagu. 
lotion a~llvetion, To ease l  the mechanism of aahogan.lnducod flbrtnotysis, 
we mouu~ l~ramaters of cougulation aotlvstion [pmthrombln fmgmenh,~ 
(F~.~), thrombln.~nttthrombln (TAT) complexes] and pemmatem d llbrinol. 
yltis potentiation ~lSUe,type ptssmlno;~n a¢tivetor (t,PA) and plasmlnogen 
~stiv~ter inhibitor (PAid) s(:tivitioa] st l~asllne and following 1 month of con- 
lugeted ~quine estrogen (GEE) 0,~5 mg administered to g postmenopeusal 
worlds, 
R~u/~: (data ,. mean ± SO): CEE marginally increased F~.= by 18 ~ 3 f % 
(P ,= 0.14) and nonsignlticanfly increased TAT by 6 ± 50% (P ,= 1.00), GEE 
reduced PAid activity by 38 ;L 30% (P - 0,03) and (ncressnd t.PA activity by 
68 • 8S% (P. 0,09), There was no association between % ~,TAT sod %,M.PA 
(r - 0,0S), and the associations between %&TAT and %SPAt.1 (r =~ 0393), 
%~F~,~ and At.PA (r = -0,60), or %.~F~,~ and %~PAI.1 (r : 0,527) were 
dtmotionally opposite anttclpatt~l correlations If potentiation of flbflnolysls was 
a result of coagulation activation, We conclude that petentiation of tibrtnolysls 
Is a prims~/eltect of GEE at the dosage used in our study and likely accounts 
for the low risk of venous thrombeambolt In postmsnopausal women taking 
at conventional dosage of fNs preparation. 
~ T h e  L-Arglnlne: Nitric O~lda Pathway Contributes 
to tho Acute Release of Tissue Plasmlnogan 
Activator In vlvo In Man 
O,E, Newhy, R,A, Wright, P, Dawson, C,A. Ludlam, N,A, Boon, K,A,A, Fox, 
03. Webb. Un/vers/ty of Edinburgh, Edinburgh, UK 
e~:k ,~:  Effective endogenous flbrinolysls requires rapid release of en- 
aoth~ilal tissue plasminogen activator (t.PA), Using the nitric oxide synthase 
inhibitor, L.Na-monomefhylarginlne (L.NMMA), we examined the contribu- 
tion of endogenous nitric oxide to substance P induced t-PA release In Wvo 
in msn. 
Methods: Blood flow and plasma fibrinolytic and hemostetic factors were 
measured in both forearms o1 8 healthy male volunteers who received uni- 
lateral brochisl artofv infusions of substance P (2.-.8 pmol/mln) and L.NMMA 
(1-4 #tg/mln), 
Resu~: Substance P caused dose-dependent increases in blood flow (p 
< 0.001) and plasma t-PA antigen (p = 0,04) and activity (p < 0,001) con- 
centretiens confined 1o the Infused forearm but had no effect on plesminogen 
activator Inhibitor type I (PAl-I) or van Wlllebrend factor concentrations. In 
the presence of L*NMMA, substance P again caused significant increases 
in blood flow (p < 0.001) and t-PA antigen (p = 0,003) and acti.:lty (p < 
0.001) concentrations but these increases were significantly less ~han with 
substance P alone (p < 0.001, p = 0`05 and p < 0,01 respectively) _-NMMA 
alone significantly reduced blood flow in the infused arm, but had no mea- 
sureable effect on t-PA or PAl-1 concentrations. 
Conclus/ons: The Loarginine:nitric oxide pathway contributes to .~ =bstance 
P induced t-PA release in viva in man, Tills orovides an impodent po- 
tentisl mechanism whereby endothelial dysfundton increases the ris~ of 
atherothrom0osts hrough e reduction in the acute fibrinolytic apacity. 
~ T h e  Estrogen Receptor AgonlaVantagonlat 
Temoxlfen Improves Endothelial Function In 
Poatmanopausal  Woman 
J, Lek~kls, C, Papamicheel, P, Athsnssladls, N. Desses, C. Vammos, 
A, Gika, A, Voutsas, S. Stsmatsiopouios, "Alexendra" Unlverslly Hosp#al, 
Athens, Greece 
Previous breast cancer tmatmont rials using tomoxtten, have reported s@- 
nltlcont reduction of cardiovascular events, Since endothelial dysfunction is 
an eady alga of aiherosclemsls, we assessed endothelial function in 13 post. 
menopousal woman recolvlng temoxlfon as monothempy lot breast ~ncer 
(mean daily deso P.1 .~ 3 mgr, duration of ~matmenl 38 4:21 months, age St ± 
9 yosm), No patient was dlal~tla of smoker, Cholesterol was 2t ? ± 28 mg/o't, 
Triglycofldes t8"/± 70 mg/dl nnd HDL chol 50 ± 20 m0/¢ll, Bmchial oftory 
diameter in response to hYl~remle flow (endotholium,de~ndanl shmulu@ 
and to aubllngual nitroglycerin (e,ldothelium.indepondent vesoddetof) was 
assessed by high resolution ultrasound imaging, Resu~ were ¢oml~lred to 
13 age and aox.matched healthy controls, Cholesterol and HOt. ehoteatefol 
ware ¢omlmtabla in two gro,Jps but Iriglycondes were higher in patXmts m- 
~ejving temoxt~n (t87 ~ 70 ve 138 ± 52 mg/dl, p = 0,05), Bsselil~ diameter, 
t~selina flow ~nd degree of rt~clivO hyperomis were similar in two groups, 
Flow,mediated dilatetion w~s hlghor in p~tiente ~ iv lng  temoxiten (125 ± ? 
ve 8 ~ 3,5%, p = 0,05) while nihoglyoefln.indgced ilatation was (mmparabte 
in two groups (2? ¢ 12 ve 25 ± 10%, ns), intimating an improvement o1 
endothelial fun(,'tion in temoxttan group, 
In ~htsk~;  this study p,ovid~ evidence thai tamoxiton IrJada Iio ira, 
prevement o! endothelial function in postmeoopausal women Ihat is inde- 
pendenl o! cholesterol reduction, which my contnbuto to a docmese m 
eaMiovascuior morbidity and mortslity in these su~.  
~ Long-term Estrogen Therapy  Improves 
Endothelial Funatlon In Women With Rayneud's 
Phenomenon 
J, t.ekakis, C, Papamichael, M. Mavnkakis, A. Vouleas, S. StamatetopeuIos. 
"Atexandra" Univ. Hosp, Athens. Greece 
Endothelial dysfunction is present in palmate with Rayneud's phenomenon 
secondary to system~ sclerosis and acute estregen edmmtstrolion can .n- 
prove this dysfunction. It ie not known whether Iong-telm estrogen therapy 
Improves endothelist function too, We therefore xamined the impact o1 tong- 
term estrogen therapy on endothelial function in 9 women with Rayneud's 
phenomenon secondary to systemic sclerosis (age 58 ± 8 years, range 
47--71 ). We used high resolution ultrasound to image the brechisl affe,'y; the 
diameter was measured at baseline, during reactive hyperem~a to assess 
flow.mediated eedothelium-dapendent dilatation (FMD) and Iollowing sublin- 
gual nitreglycenn to assess endothelium-independent vasodilatlen. FMD m 
patients (pts) was significantly lower compared to 10 female controls of simP- 
ler age (2.1 ± 1.6% vs 8.2 ± 3.2%, p = 0`000); also endothelium.independent 
dilafstlen was reduced in pls (17.6 ± 4.8% ve 26 ± 8%, p = 0.01). Patents 
were entered into a randomized, double-blind, placebo controlled, crossover 
trial (4 weeks washout phase) st conjugated estrogens (Premann 1.25 mg 
per day for 4 weeks). No significant changes were seen in vessel szze, rest 
blood flow, degree of reactive hyperemla, cholesterol, togtycendes, HDL 
LDL. Estrogen did not affect endothalium-independenf dilatation compared 
to placebo (22.6 + 9.1% vs 19.1 ± 6.9%, as). FMD was greater with estrogen 
(6.6 ± 3.5%) as compared with placebo (1.5 ± 2%, p < 0`05). In conclusion 
long term estrogen therapy markedly improves abnormal endothelial function 
in pto with Raynaud's phenomenon. This, beneficial effect is not related to 
changes of lipid profile. 
~ U s e  of  Synchrotron Radiat ion Mlcroangiography 
to  Assess Endothel lum-dependent  Relaxation of  
Microvessels in a Rat Model  o f  Hlndllmb Ischemla 
S. Takesh[ta, 1". tsshiki, Y. Mlyazawa, K. Eto, M Ochiai, E. Tanaka, H. Mori, 
T. Sato. Department of Medicine, Teikyo University Hospital, Tokyo, Japan 
Background: Current methods of anglegrephy cannot provide images of ar- 
teries measuring less than 200/~m in diameter. We have recently developed 
a new angl,~gropl.y system which employs monochromatic synchrotron ra- 
diation (SR) and high-definition video system with a spatial resolution of 30 
l~m. In the present study, usilLo this microanglegrophy system, we sought to 
document endotnelium-dependont relaxation of microvessels in the normal 
and the Ischemic rot limbs. 
Methods: tschemia was induced in one limb of rats by excision of a 
femoral artery. Thirty days later, SR microanglegraphy was performed to 
assess endothelium-dependent vasomotor esponses of microvessels (n = 
26). 
Results: SR microangiography clearly visualized the fine network of mi- 
crovessels (< 100/~m in diameter) in both the normal and the ischemic limbs. 
